General Electric R&D decreased by 1.8% to $440.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.6%, from $359.00M to $440.00M. Over 3 years (FY 2021 to FY 2025), R&D shows a downward trend with a -4.1% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $604.00M | $627.00M | $0.00 | $403.00M | $439.00M | $426.00M | $431.00M | $239.00M | $247.00M | $296.00M | $270.00M | $300.00M | $331.00M | $385.00M | $359.00M | $359.00M | $415.00M | $448.00M | $440.00M |
| QoQ Change | — | +3.8% | -100.0% | — | +8.9% | -3.0% | +1.2% | -44.5% | +3.3% | +19.8% | -8.8% | +11.1% | +10.3% | +16.3% | -6.8% | +0.0% | +15.6% | +8.0% | -1.8% |
| YoY Change | — | — | — | — | -27.3% | -32.1% | +6.9% | -45.6% | -42.0% | — | -37.4% | +25.5% | +34.0% | +30.1% | +33.0% | +19.7% | +25.4% | +16.4% | +22.6% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Commercial Engines & Services | $285.00M | $301.00M | $336.00M | $362.00M | $349.00M |
| Defense & Propulsion Technologies | $72.00M | $71.00M | $77.00M | $88.00M | $86.00M |
| Total | $359.00M | $359.00M | $415.00M | $448.00M | $440.00M |